0001567619-23-004539.txt : 20230306
0001567619-23-004539.hdr.sgml : 20230306
20230306184831
ACCESSION NUMBER: 0001567619-23-004539
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230302
FILED AS OF DATE: 20230306
DATE AS OF CHANGE: 20230306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Murugan Amar
CENTRAL INDEX KEY: 0001809916
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36548
FILM NUMBER: 23710467
MAIL ADDRESS:
STREET 1: C/O ATARA BIOTHERAPEUTICS, INC.
STREET 2: 611 GATEWAY BOULEVARD,SUITE 900
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Atara Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001604464
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 460920988
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2380 CONEJO SPECTRUM ST
STREET 2: SUITE 200
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
BUSINESS PHONE: 805-623-4244
MAIL ADDRESS:
STREET 1: 2380 CONEJO SPECTRUM ST
STREET 2: SUITE 200
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
4
1
doc1.xml
FORM 4
X0306
4
2023-03-02
0
0001604464
Atara Biotherapeutics, Inc.
ATRA
0001809916
Murugan Amar
C/O ATARA BIOTHERAPEUTICS, INC.
2380 CONEJO SPECTRUM ST, SUITE 200
THOUSAND OAKS
CA
91320
0
1
0
0
SVP, GC & Secretary
Common Stock
2023-03-02
4
S
0
4221
3.627
D
279334
D
Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations in connection with the vesting of previously granted restricted stock units.
The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on March 2, 2023 and March 3, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee.
/s/ Jeff Kiekhofer, Attorney-in-Fact for Amar Murugan
2023-03-06